Orelabrutinib, Placebo tablets match with that of orelabrutinib (ICP-022) tablets in appearance, shape, size, and weight.
ZB020-03-001
Phase 3 small_molecule active
Quick answer
Orelabrutinib, Placebo tablets match with that of orelabrutinib (ICP-022) tablets in appearance, shape, size, and weight. for Primary Progressive Multiple Sclerosis (PPMS) is a Phase 3 program (small_molecule) at Zenas BioPharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Zenas BioPharma
- Indication
- Primary Progressive Multiple Sclerosis (PPMS)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active